Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Current Research

Boy in Cambodia bravely receiving his measles shot.

Each year, measles vaccine prevents more than 1 million deaths worldwide.

CDC writes reports and articles in order to share knowledge and contribute to the improvement of immunization systems across the globe. Recent reports and articles are organized by topic below.

New report on the Global Immunization Division’s 2011-2013 research projects available here.

Note: Linking to a non-federal site does not constitute an endorsement by HHS, CDC, or any of its employees of the sponsors or the information and products presented on the site.

Current Research

Hepatitis B

  • Nguyen TH, Vu MH, Nguyen VC, Nguyen LH, Toda K, Nguyen TN, Dao S, Wannemuehler KA, Hennessey KA. A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination. Vaccine. 2014 Jan 3;32(2):217-22.
  • Mao, B., et al., Prevalence of Chronic Hepatitis B Virus Infection after Implementation of a Hepatitis B Vaccination Program among Children in Three Provinces in Cambodia. Vaccine, 2013.
  • Organization, W.H., Progress Towards Meeting the 2012 Hepatitis B Control Milestone: WHO Western Pacific Region, 2011 . Wkly Epidemiol Rec, 2011. 86(19): p. 180-188.
  • Sobel, H.L., et al., Implementing a National Policy for Hepatitis B Birth Dose Vaccination in Philippines: Lessons for Improved Delivery. Vaccine, 2011. 29(5): p. 941-5.
  • Soeung, S.C., et al., Using Data to Guide Policy: Next Steps for Preventing Perinatal Hepatitis B Virus Transmission in Cambodia. Vaccine, 2012. 31(1): p. 149-53.
  • Wallace, A.S., et al., Timing of Hepatitis B Vaccination and Impact of Non-Simultaneous Vaccination with DTP Vaccine Following Introduction of a Hepatitis B Birth Dose in the Philippines. Journal of Public Health Policy, 2012. 33(3): p. 368-381.

Measles, Rubella, and CRS

  • CDC. Rubella and Congenital Rubella Syndrome Control and Elimination — Global Progress, 2000–2012. MMWR 2013; 62(48): 983-986.
  • Papania MJ, Wallace GS, Rota PA, Icenogle JP, Fiebelkorn AP, Armstrong GL, Reef SE, Redd SB, Abernathy ES, Barskey AE, Hao L, McLean HQ, Rota JS, Bellini WJ, Seward JF. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience. JAMA Pediatr. 2014 Feb;168(2):148-55.
  • Ogbuanu IU, Zeko S, Chu SY, Muroua C, Gerber S, De Wee R, Kretsinger K, Wannemuehler K, Gerndt K, Allies M, Sandhu HS, Goodson JL. Maternal, fetal, and neonatal outcomes associated with measles during pregnancy: Namibia, 2009-2010. Clin Infect Dis. 2014 Apr;58(8):1086-92.
  • Shibeshi ME, Masresha BG, Smit SB, Biellik RJ, Nicholson JL, Muitherero C, Shivute N, Walker O, Reggis K, Goodson JL. Measles resurgence in southern Africa: challenges to measles elimination. Vaccine. 2014 Apr 1;32(16):1798-807.
  • Perry RT, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, Okwo-Bele JM, Rota PA, Goodson JL. Global control and regional elimination of measles, 2000-2012. MMWR Morb Mortal Wkly Rep. 2014 Feb 7;63(5):103-7.
  • Masresha BG, Kaiser R, Eshetu M, Katsande R, Luce R, Fall A, Dosseh AR, Naouri B, Byabamazima CR, Perry R, Dabbagh AJ, Strebel P, Kretsinger K, Goodson JL, Nshimirimana D. Progress toward measles preelimination - African region, 2011-2012. MMWR Morb Mortal Wkly Rep. 2014 Apr 4;63(13):285-91.
  • CDC. Increased transmission and outbreaks of measles--European Region, 2011. MMWR 2011; 60(47): 1605-10.
  • CDC. Measles--Horn of Africa, 2010-2011. MMWR 2012; 61(34): 678-84.
  • CDC. Progress in global measles control, 2000-2010. MMWR 2012; 61(4): 73-8.
  • CDC. Progress towards measles elimination in the Western Pacific Region, 2009-2012. MMWR 2013; 62(22): 443-7.
  • CDC. Nationwide rubella epidemic--Japan, 2013. MMWR 2013; 62(23): 457-62.
  • Cairns, K.L., et al., Should Outbreak Response Immunization be Recommended for Measles Outbreaks in Middle- and Low-Income Countries? An update. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S35-S46.
  • Castillo-Solórzano, C., et al., Elimination of Rubella and Congenital Rubella Syndrome in the Americas. Journal of Infectious Diseases, 2011. 204(suppl 2): p. S571-S578.
  • Castillo-Solorzano, C.C., et al., The Americas: Paving the Road Toward Global Measles Eradication. Journal of Infectious Diseases, 2011. 204 Suppl 1: p. S270-8.
  • Choi, W.S., et al., Outbreak of Measles in the Republic of Korea, 2007: Importance of Nosocomial Transmission. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S483-S490.
  • Christie, A.S. and Gay, A. The Measles Initiative: Moving Toward Measles Eradication. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S14-S17.
  • El Sayed, N., et al., Progress Toward Measles and Rubella Elimination in Egypt. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S318-S324.
  • Esteghamati, A., et al., Adverse Reactions Following Immunization with MMR Vaccine in Children at Selected Provinces of Iran. Arch Iran Med, 2011. 14(2): p. 91-5.
  • Goodson, J.L., et al., Research Priorities for Global Measles and Rubella Control and Eradication. Vaccine, 2012. 30(32): p. 4709-4716.
  • Goodson, J.L., et al., Rubella Epidemiology in Africa in the Prevaccine Era, 2002–2009. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S215-S225.
  • Goodson, J.L., et al., Changing Epidemiology of Measles in Africa. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S205-S214.
  • Goodson, J.L., et al., Impact of a Measles Outbreak Response Immunization Campaign: Maroua, Cameroon, 2009. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S252-S259.
  • Hickman, C.J., et al., Laboratory Characterization of Measles Virus Infection in Previously Vaccinated and Unvaccinated Individuals. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S549-S558.
  • Hoekstra, E.J., et al., Measles Supplementary Immunization Activities and GAVI Funds as Catalysts for Improving Injection Safety in Africa. Journal of Infectious Diseases, 2011. 204 Suppl 1: p. S190-7.
  • Jawad, J.S., et al., Toward Measles Elimination in Bahrain—A Middle East Country Experience. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S299-S304.
  • Kamadjeu, R., et al., Measles Control and Elimination in Somalia: The Good, the Bad, and the Ugly. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S312-S317.
  • Keegan, R., et al., Comparing Measles with Previous Eradication Programs: Enabling and Constraining Factors. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S54-S61.
  • Khetsuriani, N., et al., Supplementary Immunization Activities to Achieve Measles Elimination: Experience of the European Region. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S343-S352.
  • Kidd, S., et al., Measles Outbreak in Burkina Faso, 2009: A Case–Control Study to Determine Risk Factors and Estimate Vaccine Effectiveness. Vaccine, 2012. 30(33): p. 5000-5008.
  • Lacapère, F., et al., The Use of Rapid Coverage Monitoring in the National Rubella Vaccination Campaign, Haiti 2007–2008. Journal of Infectious Diseases, 2011. 204(suppl 2): p. S698-S705.
  • Luquero, F.J., et al., A Long-Lasting Measles Epidemic in Maroua, Cameroon 2008–2009: Mass Vaccination as Response to the Epidemic. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S243-S251.
  • Ma, C., et al., Progress Toward Measles Elimination in the People's Republic of China, 2000–2009. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S447-S454.
  • Manirakiza, A., et al., Seroprevalence of Measles and Natural Rubella Antibodies Among Children in Bangui, Central African Republic. BMC Public Health, 2011. 11(1): p. 327.
  • Mankertz, A., et al., Molecular Genotyping and Epidemiology of Measles Virus Transmission in the World Health Organization European Region, 2007–2009. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S335-S342.
  • Martin, R., et al., What Will it Take to Achieve Measles Elimination in the World Health Organization European Region: Progress from 2003–2009 and Essential Accelerated Actions. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S325-S334.
  • Masresha, B.G., et al., Measles Mortality Reduction and Pre-Elimination in the African Region, 2001–2009. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S198-S204.
  • Menegolla, I.A., et al., Outbreak of Rubella after Mass Vaccination of Children and Adult Women: Challenges for Rubella Elimination Strategies . Revista Panamericana de Salud Pública, 2011. 29(4): p. 243-251.
  • Mitruka, K., et al., Measles, Rubella, and Varicella Among the Crew of a Cruise Ship Sailing From Florida, United States, 2006. Journal of Travel Medicine, 2012. 19(4): p. 233-237.
  • Muscat, M., et al., Toward Rubella Elimination in Europe: An Epidemiological Assessment. Vaccine, 2012. 30(11): p. 1999-2007.
  • Naouri, B., et al., Progress Toward Measles Elimination in the Eastern Mediterranean Region. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S289-S298.
  • O'Connor, P.M., et al., South-East Asia Regional Update on Measles Mortality Reduction and Elimination, 2003-2008. Journal of Infectious Diseases, 2011. 204 Suppl 1: p. S396-402.
  • Rainey, J.J., et al., Haiti 2007–2008 National Measles-Rubella Vaccination Campaign: Implications for Rubella Elimination. Journal of Infectious Diseases, 2011. 204(suppl 2): p. S616-S621.
  • Reef, S.E., et al., Reducing the Global Burden of Congenital Rubella Syndrome. The Lancet, 2012. 380(9848): p. 1145-1146.
  • Reef, S.E., et al., Progress Toward Control of Rubella and Prevention of Congenital Rubella Syndrome—Worldwide, 2009. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S24-S27.
  • Rota, P.A., et al., Global Distribution of Measles Genotypes and Measles Molecular Epidemiology. Journal of Infectious Diseases, 2011. 204 Suppl 1: p. S514-23.
  • Sato, H.K., et al., Rubella Vaccination of Unknowingly Pregnant Women: The São Paulo Experience, 2001. Journal of Infectious Diseases, 2011. 204(suppl 2): p. S737-S744.
  • Segatto, C., et al., Historical Analysis of Birth Cohorts not Vaccinated against Rubella Prior to National Rubella Vaccination Campaign, Brazil. Journal of Infectious Diseases, 2011. 204(suppl 2): p. S608-S615.
  • Sever, A.E., et al., Measles Elimination in the Americas: A Comparison between Countries with a One-Dose and Two-Dose Routine Vaccination Schedule. Journal of Infectious Diseases, 2011. 204(suppl 2): p. S748-S755.
  • Simons, E., et al., Assessment of the 2010 Global Measles Mortality Reduction Goal: Results from a Model of Surveillance Data. The Lancet, 2012. 379(9832): p. 2173-2178.
  • Sniadack, D.H., et al., Epidemiology of a Measles Epidemic in Vietnam 2008–2010. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S476-S482.
  • Sniadack, D.H., et al., Progress and Challenges for Measles Elimination by 2012 in the Western Pacific Region. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S439-S446.
  • Sniadack, D.H. and W.A. Orenstein, A Measles Eradication Goal is Upon Us; Can Rubella and Congenital Rubella Syndrome be Far Behind? Vaccine, 2013. 31(24): p. 2659-60.
  • Soares, R.C., et al., Follow-Up Study of Unknowingly Pregnant Women Vaccinated against Rubella in Brazil, 2001–2002. Journal of Infectious Diseases, 2011. 204(suppl 2): p. S729-S736.
  • Strebel, P.M., et al., A World without Measles. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S1-S3.
  • Sugerman, D.E., et al., Preplanned National Measles Vaccination Campaign at the Beginning of a Measles Outbreak—Sierra Leone, 2009–2010. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S260-S269.
  • Thompson, K.M., et al., Enabling Implementation of the Global Vaccine Action Plan: Developing Investment Cases to Achieve Targets for Measles and Rubella Prevention. Vaccine, 2013. 31 Suppl 2: p. B149-56.
  • Upreti, S.R., et al., Developing Rubella Vaccination Policy in Nepal—Results from Rubella Surveillance and Seroprevalence and Congenital Rubella Syndrome Studies. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S433-S438.
  • Uzicanin, A. and Zimmerman, L., Field Effectiveness of Live Attenuated Measles-Containing Vaccines: A Review of Published Literature. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S133-S149.
  • van den Ent, M.M., et al., Measles Mortality Reduction Contributes Substantially to Reduction of All Cause Mortality among Children Less than Five Years of Age, 1990–2008. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S18-S23.
  • Vieira, J.C., et al., Survey of Rubella Knowledge and Acceptability of Rubella Vaccination among Brazilian Adults Prior to Mass Vaccination . Revista Panamericana de Salud Pública, 2011. 30(4): p. 335-341.
  • Weldegebriel, G.G., et al., Measles Resurgence Following a Nationwide Measles Vaccination Campaign in Nigeria, 2005–2008. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S226-S231.
  • Wiesen, E., et al., Stability of the Age Distribution of Measles Cases Over Time During Outbreaks in Bangladesh, 2004–2006. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S414-S420.
  • Zahraei, S.M., et al., Successful Control and Impending Elimination of Measles in the Islamic Republic of Iran. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S305-S311.
  • Zimmerman, L., et al., Toward Rubella Elimination in Poland: Need for Supplemental Immunization Activities, Enhanced Surveillance, and Further Integration with Measles Elimination Efforts. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S389-S395.
  • Zimmerman, L.A., et al., Status of Rubella and Congenital Rubella Syndrome Surveillance, 2005–2009, the World Health Organization European Region. Journal of Infectious Diseases, 2011. 204(suppl 1): p. S381-S388.

Polio Eradication

  • Iliyasu Z, Nwaze E, Verma H, Mustapha AO, Weldegebriel G, Gasasira A, Wannemuehler KA, Pallansch MA, Gajida AU, Pate M, Sutter RW. Survey of poliovirus antibodies in Kano, Northern Nigeria. Vaccine. 2014 Mar 10;32(12):1414-20.
  • Wright PF, Wieland-Alter W, Ilyushina NA, Hoen AG, Arita M, Boesch AW, Ackerman ME, van der Avoort H, Steven Oberste M, Pallansch MA, Burton AH, Jaffar MA, Sutter RW. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination. J Infect Dis. 2014 May;209(10):1628-34.
  • Duintjer Tebbens RJ, Kalkowska DA, Wassilak SG, Pallansch MA, Cochi SL, Thompson KM. The potential impact of expanding target age groups for polio immunization campaigns. BMC Infect Dis. 2014 Jan 29;14:45.
  • Diop OM, Burns CC, Wassilak SG, Kew OM. Update on vaccine-derived polioviruses - worldwide, July 2012-December 2013. MMWR Morb Mortal Wkly Rep. 2014 Mar 21;63(11):242-8.
  • Sheikh MA, Makokha F, Hussein AM, Mohamed G, Mach O, Humayun K, Okiror S, Abrar L, Nasibov O, Burton J, Unshur A, Wannemuehler K, Estivariz CF. Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities- Kenya, December 2013 . MMWR Morb Mortal Wkly Rep. 2014 Mar 21;63(11):237-41.
  • Levitt A, Diop OM, Tangermann RH, Paladin F, Kamgang JB, Burns CC, Chenoweth PJ, Goel A, Wassilak SG. Surveillance systems to track progress toward global polio eradication - worldwide, 2012-2013. MMWR Morb Mortal Wkly Rep. 2014 Apr 25;63(16):356-61.
  • Outbreak News.Outbreak of Poliomyelitis, Republic of the Congo, September 2010-February 2011. Wkly Epidemiol Rec, 2011. 86(15): p. 141-2.
  • CDC. Progress toward interruption of wild poliovirus transmission--worldwide, January 2011-March 2012. MMWR 2012; 61(19): 353-7.
  • CDC. Tracking progress toward global polio eradication, 2010-2011. MMWR 2012; 61: 265-9.
  • CDC. Progress toward Global Polio Eradication - Africa, 2011. MMWR 2012; 61(11): 190-4.
  • CDC. Expanding poliomyelitis and measles surveillance networks to establish surveillance for acute meningitis and encephalitis syndromes--Bangladesh, China, and India, 2006-2008. MMWR 2012; 61(49): 1008-11.
  • CDC. Progress toward poliomyelitis eradication - Nigeria, January 2011-September 2012. MMWR 2012; 61(44): 899-904.
  • CDC. Progress toward poliomyelitis eradication--Chad, January 2011-August 2012. MMWR 2012; 61(42): 858-62.
  • CDC. Progress toward poliomyelitis eradication - Afghanistan and Pakistan, January 2011-August 2012. MMWR 2012; 61(39): 790-5.
  • Burns, C.C., et al., Multiple Independent Emergences of Type 2 Vaccine-Derived Polioviruses During a Large Outbreak in Northern Nigeria. Journal of Virology, 2013. 87(9): p. 4907-4922.
  • Cardemil, C., et al., Surveillance During an Era of Rapidly Changing Poliovirus Epidemiology in India: The Role of One vs. Two Stool Specimens in Poliovirus Detection, 2000–2010. Epidemiology and Infection, 2013: p. 1-9.
  • Cochi, S.L. and Linkins, R.W., The Final Phase of Polio Eradication: New Vaccines and Complex Choices. Journal of Infectious Diseases, 2012. 205(2): p. 169-171.
  • de Silva, R., et al., Prevalence of Prolonged and Chronic Poliovirus Excretion Among Persons with Primary Immune Deficiency Disorders in Sri Lanka. Vaccine, 2012.
  • Doshi, S.J., et al., Poliomyelitis-Related Case-Fatality Ratio in India, 2002–2006. Clinical Infectious Diseases, 2011. 53(1): p. 13-19.
  • Duintjer Tebbens, R.J., et al., Review and Assessment of Poliovirus Immunity and Transmission: Synthesis of Knowledge Gaps and Identification of Research Needs. Risk Analysis, 2013. 33(4): p. 606-46.
  • Duintjer Tebbens, R.J., et al., Expert Review on Poliovirus Immunity and Transmission. Risk Analysis, 2013. 33(4): p. 544-605.
  • Duintjer Tebbens, R.J., et al., Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine-Derived Polioviruses (cVDPVs). Risk Analysis, 2013. 33(4): p. 680-702.
  • Estívariz, C.F., et al., Immunogenicity of Supplemental Doses of Poliovirus Vaccine for Children aged 6–9 Months in Moradabad, India: A Community-Based, Randomised Controlled Trial. The Lancet infectious diseases, 2012. 12(2): p. 128-135.
  • Estívariz, C.F., et al., Paralytic Poliomyelitis Associated with Sabin Monovalent and Bivalent Oral Polio Vaccines in Hungary. American Journal of Epidemiology, 2011. 174(3): p. 316-325.
  • Estívariz, C.F., et al., Poliovirus Vaccination Options for Achieving Eradication and Securing the Endgame. Current Opinion in Virology, 2013.
  • Geldenhuys, H., et al., Vaccine Trials in the Developing World: Operational Lessons Learnt from a Phase IV Poliomyelitis Vaccine Trial in South Africa. Vaccine, 2012.
  • Grassly, N.C., et al., Waning Intestinal Immunity after Vaccination with Oral Poliovirus Vaccines in India. Journal of Infectious Diseases, 2012. 205(10): p. 1554-1561.
  • Gregory, C.J., et al., Investigation of Elevated Case-Fatality Rate in Poliomyelitis Outbreak in Pointe Noire, Republic of Congo, 2010. Clinical Infectious Diseases, 2012. 55(10): p. 1299-1306.
  • Habib, M., et al., A Study Evaluating Poliovirus Antibodies and Risk Factors Associated with Polio Seropositivity in Low Socioeconomic Areas of Pakistan. Vaccine, 2013.
  • Jafari, H.S., Commentary: Immunologic Response to Oral Polio Vaccine in Human Immunodeficiency Virus-infected and Uninfected Zimbabwean Children. The Pediatric Infectious Disease Journal, 2012. 31(2): p. 181-183.
  • Jafari, H.S., Commentary: Polio—Can It Be Eradicated From Pakistan? The Pediatric Infectious Disease Journal, 2013. 32(3): p. 304-305.
  • Khetsuriani, N., et al., Population Immunity to Polioviruses in the Context of a Large-Scale Wild Poliovirus Type 1 Outbreak in Tajikistan, 2010. Vaccine, 2013.
  • Kidd, S., et al., Poliomyelitis Outbreaks in Angola Genetically Linked to India: Risk Factors and Implications for Prevention of Outbreaks due to Wild Poliovirus Importations. Vaccine, 2011. 29(21): p. 3760-3766.
  • Lowther, S.A., et al., World Health Organization Regional Assessments of the Risks of Poliovirus Outbreaks. Risk Analysis, 2013.
  • Mateen, F.J., Shinohara, R.T., and Sutter, R.W., Oral and Inactivated Poliovirus Vaccines in the Newborn: A Review. Vaccine, 2013. 31(21): p. 2517-2524.
  • O'Reilly, K.M., et al., The Effect of Mass Immunisation Campaigns and New Oral Poliovirus Vaccines on the Incidence of Poliomyelitis in Pakistan and Afghanistan, 2001–11: A Retrospective Analysis. The Lancet, 2012.
  • Patel, M.K., et al., An Outbreak of Wild Poliovirus in the Republic of Congo, 2010–2011. Clinical Infectious Diseases, 2012. 55(10): p. 1291-1298.
  • Resik, S., et al., Priming after a Fractional Dose of Inactivated Poliovirus Vaccine. New England Journal of Medicine, 2013. 368(5): p. 416-424.
  • Sazzad, H., et al., The Feasibility of Identifying Children with Primary Immunodeficiency Disorders: Preparation for the Polio Post-Eradication Era in Bangladesh. Vaccine, 2012. 30(36): p. 5396-5400.
  • Tebbens, R.J.D., et al., Characterizing Poliovirus Transmission and Evolution: Insights from Modeling Experiences with Wild and Vaccine‐Related Polioviruses. Risk Analysis, 2013.
  • Thacker, N., et al., Comparison of Attitudes about Polio, Polio Immunization, and Barriers to Polio Eradication between Primary Health Center Physicians and Private Pediatricians in India. International Journal of Infectious Diseases, 2012. 16(6): p. e417-e423.
  • Thacker, N., et al., Attitudes and Practices of Auxiliary Nurse Midwives and Accredited Social Health Activists in Uttar Pradesh and Bihar Regarding Polio Immunization in India. Journal of Tropical Pediatrics, 2013.
  • Thompson, K.M., et al., Preeradication Vaccine Policy Options for Poliovirus Infection and Disease Control. Risk Analysis, 2013.
  • Thompson, K.M., et al., Modeling Population Immunity to Support Efforts to End the Transmission of Live Polioviruses. Risk Analysis, 2013. 33(4): p. 647-63.
  • Thompson, K.M., et al., Modeling Population Immunity to Support Efforts to End the Transmission of Live Polioviruses. Risk Analysis, 2012.
  • Thompson, K.M., et al., Trends in the Risk of U.S. Polio outbreaks and Poliovirus Vaccine Availability for Response. Public Health Rep, 2012. 127(1): p. 23-37.
  • Waggie, Z., et al., Randomized Trial of Type 1 and Type 3 Oral Monovalent Poliovirus Vaccines in Newborns in Africa. Journal of Infectious Diseases, 2012. 205(2): p. 228-236.
  • Wassilak, S., et al., Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population. Journal of Infectious Diseases, 2011. 203(7): p. 898-909.

Strengthening Immunization Systems

  • Glass RI, Parashar U, Patel M, Gentsch J, Jiang B. Rotavirus vaccines: successes and challenges. J Infect. 2014 Jan;68 Suppl 1:S9-18.
  • Mustafa A, Makki A, Siddig O, Haithami S, Teleb N, Trivedi T, Parashar U, Patel M. Baseline burden of rotavirus disease in Sudan to monitor the impact of vaccination. Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S23-7.
  • Esparza-Aguilar M, Gastañaduy PA, Sánchez-Uribe E, Desai R, Parashar UD, Richardson V, Patel M. Diarrhoea-related hospitalizations in children before and after implementation of monovalent rotavirus vaccination in Mexico. Bull World Health Organ. 2014 Feb 1;92(2):117-25.
  • Wallace A, Kimambo S, Dafrossa L, Rusibamayila N, Rwebembera A, Songoro J, Arthur G, Luman E, Finkbeiner T, Goodson JL. Qualitative Assessment of the Integration of HIV Services With Infant Routine Immunization Visits in Tanzania. J Acquir Immune Defic Syndr. 2014 May 1;66(1):e8-e14.
  • Mwenda JM, Tate JE, Parashar UD, Mihigo R, Agócs M, Serhan F, Nshimirimana D. African rotavirus surveillance network: a brief overview. Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S6-8.
  • Pukuta ES, Esona MD, Nkongolo A, Seheri M, Makasi M, Nyembwe M, Mondonge V, Dahl BA, Mphahlele MJ, Cavallaro K, Gentsch J, Bowen MD, Waku-Kouomou D, Muyembe JJ; SURVAC Working Group. Molecular surveillance of rotavirus infection in the Democratic Republic of the Congo August 2009 to June 2012. Pediatr Infect Dis J. 2014 Apr;33(4):355-9.
  • Macneil A, Dietz V, Cherian T. Vaccine preventable diseases: Time to re-examine global surveillance data? Vaccine. 2014 Apr 25;32(20):2315-20.
  • Yen C, Tate JE, Hyde TB, Cortese MM, Lopman BA, Jiang B, Glass RI, Parashar UD. Rotavirus vaccines: Current status and future considerations. Hum Vaccin Immunother. 2014 Apr 22;10(6).
  • CDC. Ten great public health achievements--worldwide, 2001-2010. MMWR 2011; 60(24): 814-8.
  • CDC. Rotavirus surveillance --- worldwide, 2009. MMWR 2011; 60(16): 514-6.
  • CDC. Serogroup A meningococcal conjugate vaccine coverage after the first national mass immunization campaign-Burkina Faso, 2011. MMWR 2012;. 61(50): 1022-4.
  • CDC. Global routine vaccination coverage, 2012 . MMWR 2013; 62(43): 858-61.
  • CDC. Global routine vaccination coverage, 2011. MMWR 2012; 61(43): 883-5.
  • CDC. Progress in introduction of pneumococcal conjugate vaccine - worldwide, 2000-2012. MMWR 2013; 62(16): 308-11.
  • CDC. Building laboratory capacity to support the global rotavirus surveillance network. MMWR 2013; 62(20): 409-12.
  • Anand, A., Luman, E.T., and O’Connor, P.M., Building on Success—Potential to Improve Coverage of Multiple Health Interventions Through Integrated Delivery With Routine Childhood Vaccination. Journal of Infectious Diseases, 2012. 205(suppl 1): p. S28-S39.
  • Barata, R.B., et al., Socioeconomic Inequalities and Vaccination Coverage: Results of an Immunisation Coverage Survey in 27 Brazilian Capitals, 2007–2008. Journal of Epidemiology and Community Health, 2012. 66(10): p. 934-941.
  • Blau, J., et al., Indicators to Assess National Immunization Technical Advisory Groups (NITAGs). Vaccine, 2013. 31(23): p. 2653-7.
  • Briere, E.C., et al., Impact of Integration of Hygiene Kit Distribution with Routine Immunizations on Infant Vaccine Coverage and Water Treatment and Handwashing Practices of Kenyan Mothers. Journal of Infectious Diseases, 2012. 205(suppl 1): p. S56-S64.
  • Cardoso, C.W., et al., Impact of Vaccination During an Epidemic of Serogroup C Meningococcal Disease in Salvador, Brazil. Vaccine, 2012.
  • Chacon-Cruz, E., et al., Surveillance for Invasive Meningococcal Disease in Children, US–Mexico Border, 2005–2008. Emerging Infectious Diseases, 2011. 17(3): p. 543.
  • Cherian, T., Wang, S., and Mantel C., Rotavirus Vaccines in Developing Countries: the Potential Impact, Implementation Challenges, and Remaining Questions. Vaccine, 2012. 30 Suppl 1: p. A3-6.
  • Cohen, A.L., et al., Integrating Pneumonia Prevention and Treatment Interventions with Immunization Services in Resource-Poor Countries . Bulletin of the World Health Organization, 2012. 90(4): p. 289-294.
  • Date, K.A., et al., Considerations for Oral Cholera Vaccine Use during Outbreak after Earthquake in Haiti, 2010− 2011. Emerging Infectious Diseases, 2011. 17(11): p. 2105.
  • de Carvalho, C.X., et al., Carriage of Haemophilus Influenzae among Brazilian Children Attending Day Care Centers in the Era of Widespread Hib Vaccination. Vaccine, 2011. 29(7): p. 1438-1442.
  • de Oliveira, L.H., et al., Progress in the Introduction of the Rotavirus Vaccine in Latin America and the Caribbean: Four Years of Accumulated Experience. The Pediatric Infectious Disease Journal, 2011. 30(1 Suppl): p. S61-6.
  • do Carmo, G.M.I., et al., Decline in Diarrhea Mortality and Admissions after Routine Childhood Rotavirus Immunization in Brazil: A Time-Series Analysis. PLoS Medicine, 2011. 8(4): p. e1001024.
  • Duclos, P., et al., Monitoring of Progress in the Establishment and Strengthening of National Immunization Technical Advisory Groups. Vaccine, 2012. 30(50): p. 7147-7152.
  • Flannery, B., et al., Uptake of Oral Rotavirus Vaccine and Timeliness of Routine Immunization in Brazil's National Immunization Program. Vaccine, 2013. 31(11): p. 1523-8.
  • Garcia, S., et al., Impact of Vaccination against Haemophilus Influenzae Type b with and without a Booster Dose on Meningitis in Four South American Countries. Vaccine, 2012. 30(2): p. 486-492.
  • Gargano, L.M., et al., Attitudes of Pediatricians and Primary Health Center Physicians in India Concerning Routine Immunization, Barriers to Vaccination, and Missed Opportunities to Vaccinate. The Pediatric Infectious Disease Journal, 2012. 31(2): p. e37-e42.
  • Gargano, L.M., et al., Predictors of Administration and Attitudes about Pneumococcal, Haemophilus Influenzae Type b and Rotavirus Vaccines among Pediatricians in India: A National Survey. Vaccine, 2012. 30(24): p. 3541-5.
  • Goodson, J.L., et al., Evaluation of Using Routine Infant Immunization Visits to Identify and Follow-Up HIV-Exposed Infants and their Mothers in Tanzania. J Acquir Immune Defic Syndr, 2013. 63(1): p. e9-e15.
  • Goodson, J.L., et al., Improved Equity in Measles Vaccination from Integrating Insecticide‐Treated Bednets in a Vaccination Campaign, Madagascar. Tropical Medicine & International Health, 2012. 17(4): p. 430-437.
  • Hyde, T.B., et al., The Impact of New Vaccine Introduction on Immunization and Health Systems: A Review of the Published Literature. Vaccine, 2012. 30(45): p. 6347-58.
  • Jauregui, B., et al., Strengthening the Technical Capacity at Country-Level to Make Informed Policy Decisions on New Vaccine Introduction: Lessons Learned by PAHO's ProVac Initiative. Vaccine, 2011. 29(5): p. 1099-106.
  • Miles, M., et al., Validity of Vaccination Cards and Parental Recall to Estimate Vaccination Coverage: A Systematic Review of the Literature. Vaccine, 2012.
  • Mirza, I.R., et al., Somalia: Supporting the Child Survival Agenda when Routine Health Service is Broken. J Infect Dis, 2012. 205 Suppl 1: p. S126-33.
  • Lee, L.A., et al., The Estimated Mortality Impact of Vaccinations Forecast to be Administered during 2011-2020 in 73 Countries Supported by the GAVI Alliance. Vaccine, 2013. 31 Suppl 2: p. B61-72.
  • Liu, N., et al., Projected Health Impact and Cost-Effectiveness of Rotavirus Vaccination among Children <5 Years of Age in China. Vaccine, 2012. 30(48): p. 6940-5.
  • Mantel, C. and Wang, S. A., The Privilege and Responsibility of Having Choices: Decision-Making for New Vaccines in Developing Countries. Health Policy and Planning, 2012. 27(suppl 2): p. ii1-ii4.
  • Markowitz, L.E., et al., Human Papillomavirus Vaccine Introduction--The First Five Years. Vaccine, 2012. 30 Suppl 5: p. F139-48.
  • Patel, M.M., et al., Intussusception Risk and Health Benefits of Rotavirus Vaccination in Mexico and Brazil. N Engl J Med, 2011. 364(24): p. 2283-92.
  • Pradhan, N., et al., Expanding and Improving Urban Outreach Immunization in Patna, India. Tropical Medicine & International Health, 2012. 17(3): p. 292-299.
  • Rainey, J.J., et al., Vaccination Coverage in Haiti: Results from the 2009 National Survey. Vaccine, 2012. 30(9): p. 1746-1751.
  • Rainey, J.J., et al., Reasons Related to Non-Vaccination and Under-Vaccination of Children in Low and Middle Income Countries: Findings from a Systematic Review of the Published Literature, 1999–2009. Vaccine, 2011. 29(46): p. 8215-8221.
  • Rodewald, L.E., Notes from the Field: My Experience in China with WHO. Pediatr Ann, 2013. 42(6): p. 253-5.
  • Ryman, T.K., et al., Integration of Routine Vaccination and Hygiene Interventions: A Comparison of 2 Strategies in Kenya. Journal of Infectious Diseases, 2012. 205(suppl 1): p. S65-S76.
  • Ryman, T.K., et al., Contribution of Immunization Weeks Toward Improving Coverage, Access to Services, and Completion of Recommended Childhood Vaccinations in Assam, India. Vaccine, 2012. 30(15): p. 2551-2555.
  • Ryman, T.K., et al., Implementation and Evaluation of the Reaching Every District (RED) Strategy in Assam, India, 2005–2008. Vaccine, 2011. 29(14): p. 2555-2560.
  • Ryman, T.K., et al., Community and Health Worker Perceptions and Preferences Regarding Integration of Other Health Services With Routine Vaccinations: Four Case Studies. Journal of Infectious Diseases, 2012. 205(suppl 1): p. S49-S55.
  • Sangh, H.K.N., Implementation of the Reaching Every District (RED) Approach: Experience from North Sudan. Eastern Mediterranean Health Journal, 2011: p. 17.
  • Slayton, R.B., Date, K. A., and Mintz, E.D., Vaccination for Typhoid Fever in Sub-Saharan Africa. Hum Vaccin Immunother, 2013. 9(4).
  • Sosler, S., Population Level Assessments of Immunization-When More Complex is Better. Indian Pediatrics, 2012. 49(2): p. 99-102.
  • Upreti, S.R., et al., Estimation of theImpact of a Japanese Encephalitis Immunization Program with Live, Attenuated SA 14-14-2 Vaccine in Nepal. Am J Trop Med Hyg, 2013. 88(3): p. 464-8.
  • Vijayaraghavan, M., et al., Economic Evaluation of a Child Health Days Strategy to Deliver Multiple Maternal and Child Health Interventions in Somalia. Journal of Infectious Diseases, 2012. 205(suppl 1): p. S134-S140.
  • von Gottberg, A., et al., Invasive Disease due to Haemophilus Influenzae Serotype b Ten Years after Routine Vaccination, South Africa, 2003-2009. Vaccine, 2012. 30(3): p. 565-71.
  • Wallace, A., et al., Strengthening Evidence-Based Planning of Integrated Health Service Delivery through Local Measures of Health Intervention Delivery Times. Journal of Infectious Diseases, 2012. 205(suppl 1): p. S40-S48.
  • Wallace, A.S., Ryman., T.K., and Dietz, V., Experiences Integrating Delivery of Maternal and Child Health Services with Childhood Immunization Programs: Systematic Review Update. Journal of Infectious Diseases, 2012. 205(suppl 1): p. S6-S19.
  • Wang, S.A., et al., New Vaccine Introductions: Assessing the Impact and the Opportunities for Immunization and Health Systems Strengthening. Vaccine, 2013. 31 Suppl 2: p. B122-8.
  • Wei, S.C., et al., Validity of Expanded Program on Immunization Contact Method Health Behavior Estimates in Mali. Journal of Infectious Diseases, 2012. 205(suppl 1): p. S112-S119.
  • Yin, Z., et al., An Economic Evaluation of the use of Japanese Encephalitis Vaccine in the Expanded Program of Immunization of Guizhou Province, China. Vaccine, 2012. 30(37): p. 5569-77.

Other Vaccine-Preventable Diseases

  • Li Y, Yin Z, Shao Z, Li M, Liang X, Sandhu HS, Hadler SC, Li J, Sun Y, Li J, Zou W, Lin M, Zuo S, Mayer LW, Novak RT, Zhu B, Xu L, Luo H; Acute Meningitis and Encephalitis Syndrome Study Group. Population-based surveillance for bacterial meningitis in China, September 2006-December 2009. Emerg Infect Dis. 2014 Jan;20(1):61-9
  • Scobie HM, Nilles E, Kama M, Kool JL, Mintz E, Wannemuehler KA, Hyde TB, Dawainavesi A, Singh S, Korovou S, Jenkins K, Date K. Impact of a Targeted Typhoid Vaccination Campaign Following Cyclone Tomas, Republic of Fiji, 2010. Am J Trop Med Hyg. 2014 Apr 7. [Epub ahead of print ]
  • Barzilay, E.J., et al., Cholera Surveillance during the Haiti Epidemic--The First 2 Years. N Engl J Med, 2013. 368(7): p. 599-609.
  • Impoinvil, D.E., et al., The Spatial Heterogeneity between Japanese Encephalitis Incidence Distribution and Environmental Variables in Nepal. PloS one, 2011. 6(7): p. e22192.
  • Kim, J.H., et al., Adverse Events Following Immunization (AEFI) with the Novel Influenza A (H1N1) 2009 Vaccine: Findings from the National Registry of all Vaccine Recipients and AEFI and the Passive Surveillance System in South Korea. Jpn J Infect Dis, 2012. 65(2): p. 99-104.
  • Paul, R.C., et al., A Novel Low-Cost Approach to Estimate the Incidence of Japanese Encephalitis in the Catchment Area of Three Hospitals in Bangladesh. The American Journal of Tropical Medicine and Hygiene, 2011. 85(2): p. 379.
 
  • Page last reviewed: January 27, 2014
  • Page last updated: January 27, 2014
  • Content source: Global Health
  • Notice: Linking to a non-federal site does not constitute an endorsement by HHS, CDC or any of its employees of the sponsors or the information and products presented on the site.
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO